GlassScriptPhysician profile
Natalia Baran
NPI 1992122147
$1,040.16
in general payments reported to CMS, 2019-2025
17 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $38.84 · 2021: $271 · 2022: $96.66 · 2023: $133 · 2024: $261 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $394.34 | 2020-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $143.62 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| E.R. Squibb & Sons, L.L.C. | $88.24 | 2023-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $57.48 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.34 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.56 | 2025 | Xifaxan |
| Philips North America LLC | $34.64 | 2021 | |
| Alexion Pharmaceuticals, INC. | $30.60 | 2025 | |
| Pfizer INC. | $26.79 | 2024 | |
| Recor Medical INC | $25.78 | 2024 | Paradise Renal Denervation System |
| Insmed, INC. | $24.65 | 2025 | Arikayce |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.78 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $20.34 | 2021 | |
| Allergan, INC. | $19.89 | 2020 | |
| Amgen INC. | $19.32 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $16.04 | 2025 | Veklury |
| Abbvie INC. | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Baran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.